


The global ERCP guidewire market is valued at US$388.1 million in 2025 and is forecast to reach US$450.2 million by 2031, a compound annual growth rate (CAGR) of 2.5% over 2025-2031. Volume is estimated at 2.99 million wires in 2025, rising to 3.65 million by 2031 (3.4% CAGR). The report covers single-use guidewires sold for endoscopic retrograde cholangiopancreatography (ERCP) at net selling price to hospitals and distributors. Guidewires for other procedures, duodenoscopes, sphincterotomes, stents, balloons and baskets are excluded.
The report segments the market by four wire diameters and two application settings across five regions and 24 country-level lines. The 0.035 Inch segment is the largest (US$195.6 million, 50.4% of 2025 value) and the 0.025 Inch segment is the fastest growing (4.9% CAGR). North America is the largest region (42.1% of 2025 value) and Middle East and Africa is the fastest growing (4.3% CAGR). Public Hospital accounts for about 62% of 2025 value. Market values are Navadhi Market Research estimates built bottom-up from ERCP procedure counts, wires per procedure and net price per wire; most company revenues are group totals because ERCP guidewire sales are not separately disclosed.
Scope of the Global ERCP Guidewire Market Strategic Research Report
This report covers market value (US$ million) and volume (thousand wires) for 2022-2031, with 2025 as the base year and 2026-2031 as the forecast period. It analyses four wire diameters, two application settings, five regions and 24 country-level lines, and includes company profiles for 16 companies, competitive landscape, Porter's Five Forces, PESTLE, SWOT and future trends, with low and high growth scenarios.
Segment by Type
Segment by Application
Who Can Use This Report?
1. Executive Summary
1.1 Market Definition and Headline Sizing
1.2 Principal Growth Drivers
1.3 Segment and Regional Highlights
1.4 Competitive Structure
1.5 Principal Risks
1.6 Outlook
2. Industry Overview & Forecast
2.1 Market Definition and Scope
2.2 Market Size and Historical Performance
2.3 Forecast and Growth Logic
2.4 Volume Analysis
2.5 Value Chain and Pricing Architecture
3. Market Segmentation by Type
3.1 Overview of the Type Segmentation Framework
3.2 Volume Analysis
3.2.1 Global Wire Volume, 2022–2031
3.3 Guidewires of 0.025 Inch Diameter
3.3.1 Definition and Clinical Applications
3.3.2 Market Size and Share
3.3.3 2025–2031 Growth Trajectory
3.3.4 Demand Drivers
3.3.5 Technology and Pricing Dynamics
3.3.6 Key Suppliers and Risks
3.4 Guidewires of 0.032 Inch Diameter
3.4.1 Definition and Clinical Applications
3.4.2 Market Size and Share
3.4.3 2025–2031 Growth Trajectory
3.4.4 Demand Drivers
3.4.5 Technology and Pricing Dynamics
3.4.6 Key Suppliers and Risks
3.5 Guidewires of 0.035 Inch Diameter
3.5.1 Definition and Clinical Applications
3.5.2 Market Size and Share
3.5.3 2025–2031 Growth Trajectory
3.5.4 Demand Drivers
3.5.5 Technology and Pricing Dynamics
3.5.6 Key Suppliers and Risks
3.6 Other Diameters (0.018 Inch, 0.021 Inch, and Related Formats)
3.6.1 Definition and Clinical Applications
3.6.2 Market Size and Share
3.6.3 2025–2031 Growth Trajectory
3.6.4 Demand Drivers
3.6.5 Technology and Pricing Dynamics
3.6.6 Key Suppliers and Risks
3.7 Comparative Diameter Mix Shift and Strategic Implications
4. Market Segmentation by Application
4.1 Overview and Structural Logic of the Application Segmentation
4.1.1 Public Hospital
4.1.1.1 Segment Definition and Clinical Context
4.1.1.2 Market Size, Share, and Forecast
4.1.1.3 Buyer Behaviour and Procurement Patterns
4.1.1.4 Facility-Level Consumption and Clinical Load
4.1.1.5 Risks to the Segment
4.1.2 Private Hospital
4.1.2.1 Segment Definition and Clinical Context
4.1.2.2 Market Size, Share, and Forecast
4.1.2.3 Buyer Behaviour and Procurement Patterns
4.1.2.4 Facility-Level Consumption and Clinical Load
4.1.2.5 Risks to the Segment
4.1.3 Comparative Analysis of Public and Private Hospital Segments
5. Regional Market Forecast
5.1 North America
5.1.1 Regional Overview
5.1.2 Key Growth Drivers
5.1.3 Regulatory & Infrastructure Landscape
5.1.4 Country-Level Analysis
5.1.5 Market Forecast 2025–2031
5.2 Europe
5.2.1 Regional Overview
5.2.2 Key Growth Drivers
5.2.3 Regulatory & Infrastructure Landscape
5.2.4 Country-Level Analysis
5.2.5 Market Forecast 2025–2031
5.3 Asia Pacific
5.3.1 Regional Overview
5.3.2 Key Growth Drivers
5.3.3 Regulatory & Infrastructure Landscape
5.3.4 Country-Level Analysis
5.3.5 Market Forecast 2025–2031
5.4 Latin America
5.4.1 Regional Overview
5.4.2 Key Growth Drivers
5.4.3 Regulatory & Infrastructure Landscape
5.4.4 Country-Level Analysis
5.4.5 Market Forecast 2025–2031
5.5 Middle East and Africa
5.5.1 Regional Overview
5.5.2 Key Growth Drivers
5.5.3 Regulatory & Infrastructure Landscape
5.5.4 Country-Level Analysis
5.5.5 Market Forecast 2025–2031
6. Country-Level Market Forecast
6.1 North America
6.1.1 United States
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 United Kingdom
6.2.4 Italy
6.2.5 Russia
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 China
6.3.2 Japan
6.3.3 South Korea
6.3.4 Southeast Asia
6.3.5 India
6.3.6 Australia
6.3.7 Rest of Asia Pacific
6.4 Latin America
6.4.1 Brazil
6.4.2 Rest of Latin America
6.5 Middle East and Africa
6.5.1 Egypt
6.5.2 South Africa
6.5.3 Israel
6.5.4 Turkey
6.5.5 GCC Countries
6.5.6 Rest of Middle East and Africa
7. Growth Drivers & Inhibitors
7.1 Market Drivers
7.2 Market Restraints
7.3 Impact Assessment Summary
7.4 Integrated Assessment
8. Key Company Profiles
8.1 Boston Scientific
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2025–2031)
8.2 Olympus
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2025–2031)
8.3 Cook Medical
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2025–2031)
8.4 CONMED
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2025–2031)
8.5 Terumo Medical
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2025–2031)
8.6 MICRO-TECH (Nanjing) Co.
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2025–2031)
8.7 Hangzhou AGS MedTech
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2025–2031)
8.8 SCW Medicath
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2025–2031)
8.9 Advin Health Care
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2025–2031)
8.10 Leo Medical
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2025–2031)
8.11 Medorah Meditek
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2025–2031)
8.12 Diagmed Healthcare
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2025–2031)
8.13 Medi-Globe GmbH
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2025–2031)
8.14 Zeus Company
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2025–2031)
8.15 Piolax Medical Devices
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2025–2031)
8.16 Mediskope
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2025–2031)
9. Competitive Landscape
9.1 Competitive Landscape Overview
9.1.1 Profiled Participants and Available Financial Data
9.1.2 Why Market Concentration Cannot Be Measured
9.1.3 Competitive Intensity and Market Positioning
9.2 Competitive Intensity Assessment
9.2.1 Structural Composition of the Competitive Field
9.2.2 Capacity Relative to Demand Dynamics
9.2.3 Pricing Environment: Premium, Value and Commoditised Segments
9.2.4 Barriers to Entry and Exit
9.3 Key Player Strategies & Positioning
9.3.1 Strategic Group Architecture
9.3.2 Major Player Differentiation Strategies
9.3.3 Geographic Strongholds
9.3.4 M&A, Partnerships, and R&D Investment Trends
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 The Competitive Field: Structure and Information Constraints
9.4.2 Incumbent Positioning: Scale Asymmetry and Its Implications
9.4.3 Emerging Competitive Threats
9.4.4 Consolidation vs. Fragmentation Outlook
9.4.5 Competitive Response Matrix
9.4.6 Strategic Recommendations for 2026–2031
10. Porter's Five Forces Analysis
10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry
11. PESTLE Analysis
11.1 Strategic Environmental Assessment, 2026–2031
11.2 Overview
11.3 Political
11.4 Economic
11.5 Sociocultural
11.6 Technological
11.7 Legal
11.8 Environmental
11.9 PESTLE Summary Assessment Table
12. SWOT Analysis
12.1.1 Detailed Analysis
12.1.1.1 Strengths
12.1.1.2 Weaknesses
12.1.1.3 Opportunities
12.1.1.4 Threats
12.1.2 Strategic Implications and Priority Actions
13. Future Trends & Outlook
13.1 Overview
13.2 Dominant Trends Shaping the Market Through 2031
13.2.1 Diameter-Driven Portfolio Bifurcation
13.2.2 Asia Pacific's Procedural Surge and Its Dual Price-Volume Dynamic
13.2.3 Private Hospital Expansion as the Premium Demand Engine
13.2.4 Middle East, Africa, and Latin America
13.2.5 North America's Procedural Maturity and the Price Floor Dynamic
13.2.6 Scenario Divergence: The Risk Corridor Widens Post-2026
13.2.7 Competitive Concentration and the Undisclosed-Revenue Majority
13.3 Trend Summary Table
13.4 Forward Outlook
List of Exhibits
Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.2: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.3: Forecast of Global Market (in USD Mn)
Exhibit 2.4: Forecast of North America (in USD Mn)
Exhibit 2.5: Forecast of Europe (in USD Mn)
Exhibit 2.6: Forecast of Asia Pacific (in USD Mn)
Exhibit 2.7: Forecast of Latin America (in USD Mn)
Exhibit 2.8: Forecast of Middle East and Africa (in USD Mn)
Exhibit 2.9: Forecast of Global Market (in K Wires)
Exhibit 2.10: Forecast of North America (in K Wires)
Exhibit 2.11: Forecast of Europe (in K Wires)
Exhibit 2.12: Forecast of Asia Pacific (in K Wires)
Exhibit 2.13: Forecast of Latin America (in K Wires)
Exhibit 2.14: Forecast of Middle East and Africa (in K Wires)
Exhibit 3.15: Forecast of 0.025 Inch (in USD Mn)
Exhibit 3.16: Forecast of 0.025 Inch (in K Wires)
Exhibit 3.17: Forecast of 0.032 Inch (in USD Mn)
Exhibit 3.18: Forecast of 0.035 Inch (in USD Mn)
Exhibit 3.19: Forecast of 0.032 Inch (in K Wires)
Exhibit 3.20: Forecast of 0.035 Inch (in K Wires)
Exhibit 3.21: Forecast of Other Diameters (in USD Mn)
Exhibit 3.22: Forecast of Other Diameters (in K Wires)
Exhibit 4.23: Forecast of Public Hospital (in USD Mn)
Exhibit 4.24: Forecast of Public Hospital (in K Wires)
Exhibit 4.25: Forecast of Private Hospital (in USD Mn)
Exhibit 4.26: Forecast of Private Hospital (in K Wires)
Exhibit 6.27: Forecast of North America (in USD Mn)
Exhibit 6.28: Forecast of United States (in USD Mn)
Exhibit 6.29: Forecast of Canada (in USD Mn)
Exhibit 6.30: Forecast of Mexico (in USD Mn)
Exhibit 6.31: Forecast of North America (in K Wires)
Exhibit 6.32: Forecast of United States (in K Wires)
Exhibit 6.33: Forecast of Canada (in K Wires)
Exhibit 6.34: Forecast of Mexico (in K Wires)
Exhibit 6.35: Forecast of Europe (in USD Mn)
Exhibit 6.36: Forecast of Germany (in USD Mn)
Exhibit 6.37: Forecast of France (in USD Mn)
Exhibit 6.38: Forecast of United Kingdom (in USD Mn)
Exhibit 6.39: Forecast of Italy (in USD Mn)
Exhibit 6.40: Forecast of Russia (in USD Mn)
Exhibit 6.41: Forecast of Rest of Europe (in USD Mn)
Exhibit 6.42: Forecast of Europe (in K Wires)
Exhibit 6.43: Forecast of Germany (in K Wires)
Exhibit 6.44: Forecast of France (in K Wires)
Exhibit 6.45: Forecast of United Kingdom (in K Wires)
Exhibit 6.46: Forecast of Italy (in K Wires)
Exhibit 6.47: Forecast of Russia (in K Wires)
Exhibit 6.48: Forecast of Rest of Europe (in K Wires)
Exhibit 6.49: Forecast of Asia Pacific (in USD Mn)
Exhibit 6.50: Forecast of China (in USD Mn)
Exhibit 6.51: Forecast of Japan (in USD Mn)
Exhibit 6.52: Forecast of South Korea (in USD Mn)
Exhibit 6.53: Forecast of Southeast Asia (in USD Mn)
Exhibit 6.54: Forecast of India (in USD Mn)
Exhibit 6.55: Forecast of Australia (in USD Mn)
Exhibit 6.56: Forecast of Rest of Asia Pacific (in USD Mn)
Exhibit 6.57: Forecast of Asia Pacific (in K Wires)
Exhibit 6.58: Forecast of China (in K Wires)
Exhibit 6.59: Forecast of Japan (in K Wires)
Exhibit 6.60: Forecast of South Korea (in K Wires)
Exhibit 6.61: Forecast of Southeast Asia (in K Wires)
Exhibit 6.62: Forecast of India (in K Wires)
Exhibit 6.63: Forecast of Australia (in K Wires)
Exhibit 6.64: Forecast of Rest of Asia Pacific (in K Wires)
Exhibit 6.65: Forecast of Latin America (in USD Mn)
Exhibit 6.66: Forecast of Brazil (in USD Mn)
Exhibit 6.67: Forecast of Rest of Latin America (in USD Mn)
Exhibit 6.68: Forecast of Latin America (in K Wires)
Exhibit 6.69: Forecast of Brazil (in K Wires)
Exhibit 6.70: Forecast of Rest of Latin America (in K Wires)
Exhibit 6.71: Forecast of Middle East and Africa (in USD Mn)
Exhibit 6.72: Forecast of Egypt (in USD Mn)
Exhibit 6.73: Forecast of South Africa (in USD Mn)
Exhibit 6.74: Forecast of Israel (in USD Mn)
Exhibit 6.75: Forecast of Turkey (in USD Mn)
Exhibit 6.76: Forecast of GCC Countries (in USD Mn)
Exhibit 6.77: Forecast of Rest of Middle East and Africa (in USD Mn)
Exhibit 6.78: Forecast of Middle East and Africa (in K Wires)
Exhibit 6.79: Forecast of Egypt (in K Wires)
Exhibit 6.80: Forecast of South Africa (in K Wires)
Exhibit 6.81: Forecast of Israel (in K Wires)
Exhibit 6.82: Forecast of Turkey (in K Wires)
Exhibit 6.83: Forecast of GCC Countries (in K Wires)
Exhibit 6.84: Forecast of Rest of Middle East and Africa (in K Wires)
*If Applicable.